-
Symbol
-
TRAW on Nasdaq
-
Investment type
-
Equity / Common stock, par value $.01 per share
-
Latest Disclosed Shares Owned
-
812,524 shares
-
Security Ownership %
-
10%
Shares, Excluding Options vs Price
Ikarian Capital, LLC ownership in Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW)
17 Feb 2026 - Ikarian Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 812,524 shares of Traws Pharma, Inc. Common stock, par value $.01 per share (TRAW).
This represents 10% ownership of the company.
In their previous filing dated 15 May 2025, Ikarian Capital, LLC had reported owning 589,502 shares, indicating an increase of +38%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.